Figure 1From: Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disabilityCumulative risk of being persistent on therapy over 2 years of follow-up. Persistence decreased from 98% at visit 2 (2.15 ± 0.44 months of follow-up) to 34% at visit 13 (24.6 ± 6.17 months of follow-up).Back to article page